Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
05 2020
Historique:
received: 11 06 2019
accepted: 14 02 2020
pubmed: 29 2 2020
medline: 17 2 2021
entrez: 29 2 2020
Statut: epublish

Résumé

COPD patients often use many medical resources, such as hospital admissions and medical imaging, inappropriately close to death. Palliative home care (PHC) could beneficially affect this. The aim was to study the effect of use and timing of PHC on medical resource use and costs in the last 30 days before death (DBD) for COPD.We performed a retrospective study of all Belgian decedents in 2010-2015 with COPD and a primary cause of death being COPD or cardiovascular diseases. Odds ratios for medical resources were calculated between using and four PHC timing categories (>360, 360-181, 180-91 and 90-31 DBD)

Identifiants

pubmed: 32108048
pii: 13993003.01139-2019
doi: 10.1183/13993003.01139-2019
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: C. Scheerens has nothing to disclose. Conflict of interest: K. Faes has nothing to disclose. Conflict of interest: P. Pype has nothing to disclose. Conflict of interest: K. Beernaert has nothing to disclose. Conflict of interest: G. Joos has nothing to disclose. Conflict of interest: E. Derom has nothing to disclose. Conflict of interest: J. Cohen has nothing to disclose. Conflict of interest: L. Deliens has nothing to disclose. Conflict of interest: K. Chambaere has nothing to disclose.

Auteurs

Charlotte Scheerens (C)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium charlotte.scheerens@ugent.be.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Kristof Faes (K)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Peter Pype (P)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Kim Beernaert (K)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Guy Joos (G)

Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Dept of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Eric Derom (E)

Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Dept of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.

Joachim Cohen (J)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Luc Deliens (L)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Public Health and Primary Care, Ghent University, Ghent, Belgium.
Dept of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Contributed equally as last author.

Kenneth Chambaere (K)

End-of-Life Care Research Group, Ghent University, Ghent, Belgium.
End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Dept of Public Health and Primary Care, Ghent University, Ghent, Belgium.
Contributed equally as last author.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH